Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Vaccines
Sanofi agrees to help manufacture Moderna’s COVID-19 vaccine
by Megha Satyanarayana
April 30, 2021
| A version of this story appeared in
Volume 99, Issue 16
Sanofi has agreed to manufacture up to 200 million finished doses of Moderna’s COVID-19 vaccine at its facility in Ridgefield, New Jersey. Combined with prior agreements to make 125 million doses of the Pfizer-BioNTech vaccine for the European Union and 12 million doses of the Johnson & Johnson vaccine for France, the pact with Moderna makes Sanofi the only large company to be involved in making all three of these COVID-19 vaccines.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X